1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > IMS Country Review 2016: Portugal

IMS Country Review 2016: Portugal

  • July 2016
  • -
  • IMS Health
  • -
  • 81 pages

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Table Of Contents

IMS Country Review 2016: Portugal
Table of Contents
SECTION 1: SYNOPSIS OF THE HEALTHCARE MARKET 5
MARKET TRENDS 5
HEALTHCARE PROVISION 5
PRESCRIBING POLICY 6
PRICING SYSTEM 7
REGULATORY ENVIRONMENT 8
INDUSTRY ENVIRONMENT 8
CHANNELS OF DISTRIBUTION 10
PORTUGAL DATA COLLECTION 11
SECTION 2: COUNTRY SALES PERFORMANCE AND TRENDS 12
FIGURE 1: COUNTRY RANKING AMONGST 30 MARKETS WORLDWIDE 12
FIGURE 2: AUDITED MARKET TREND 13
FIGURE 3: LEADING 35 LOCAL COMPANIES 14
FIGURE 4: LEADING 35 CORPORATIONS 16
FIGURE 5: MARKET SHARE BY CORPORATE NATIONALITY 18
FIGURE 6: LEADING 15 THERAPEUTIC CLASSES (LEVEL 3) 2015 19
FIGURE 7: 15 FASTEST-GROWING THERAPEUTIC CLASSES (LEVEL 3) 2015 20
FIGURE 8-22: LEADING 15 THERAPEUTIC CLASS PROFILES 21
FIGURE 8: A10N DPP-IV INHIBITOR A-DIABS 21
FIGURE 9: A10P SGLT2 INHIBITOR A-DIABS 22
FIGURE 10: A10S GLP-1 AGONIST A-DIABS 23
FIGURE 11: B1F DIRECT FACTOR XA INHIBS 24
FIGURE 12: C9D ANGIOTEN-II ANTAG, COMB 25
FIGURE 13: C10A CHOLESTandTRIGLY.REGULATOR 26
FIGURE 14: J5B ANTIVIRALS EXCL ANTI-HIV 27
FIGURE 15: J5C HIV ANTIVIRALS 28
FIGURE 16: J7D BACTERIAL VACCINES 29
FIGURE 17: L1G MAB ANTINEOPLASTICS 30
FIGURE 18: L1H PROTEIN KINASE INH A-NEO 31
FIGURE 19: L4B ANTI-TNF PRODUCTS 32
FIGURE 20: N5A ANTIPSYCHOTICS 33
FIGURE 21: N6A ANTIDEPRESS.and MOOD STAB. 34
FIGURE 22: P1B ANTHELMINTICS 35
FIGURE 23: LEADING 40 PRODUCTS 36
FIGURE 24: LEADING 40 NEW PRODUCTS 38
FIGURE 25: LEADING 15 PRODUCT FORMS 41
FIGURE 26: FASTEST GROWING 40 PRODUCTS SALES TRENDS 42
SECTION 3: APPENDICES 44
APPENDIX 1: AUDITED UNIVERSE 44
APPENDIX 2: COUNTRY SPECIFIC ALERTS 45
APPENDIX 3: MEASURE INDEX 48
APPENDIX 4: SALES DATA MEASURES 50
APPENDIX 5: *LATEST FACTORS 52
APPENDIX 6: QUARTERLY US$ EXCHANGE RATES BY COUNTRY 56
APPENDIX 7: CORPORATIONS 58
APPENDIX 8: PRODUCT NAMES 59
APPENDIX 9: THERAPIES 61
APPENDIX 10: EPHMRA ANATOMICAL THERAPEUTIC CLASSIFICATION 62

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides a comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.